Literature DB >> 28406525

An improved radiosynthesis of O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate: A first-in-class cholinesterase PET tracer.

Kiel D Neumann1, Charles M Thompson2, Joseph E Blecha1, John M Gerdes2, Henry F VanBrocklin1.   

Abstract

O-(2-Fluoroethyl)-O-(p-nitrophenyl) methylphosphonate 1 is an organophosphate cholinesterase inhibitor that creates a phosphonyl-serine covalent adduct at the enzyme active site blocking cholinesterase activity in vivo. The corresponding radiolabeled O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl) methylphosphonate, [18 F]1, has been previously prepared and found to be an excellent positron emission tomography imaging tracer for assessment of cholinesterases in live brain, peripheral tissues, and blood. However, the previously reported [18 F]1 tracer synthesis was slow even with microwave acceleration, required high-performance liquid chromatography separation of the tracer from impurities, and gave less optimal radiochemical yields. In this paper, we report a new synthetic approach to circumvent these shortcomings that is reliant on the facile reactivity of bis-(O,O-p-nitrophenyl) methylphosphonate, 2, with 2-fluoroethanol in the presence of DBU. The cold synthesis was successfully translated to provide a more robust radiosynthesis. Using this new strategy, the desired tracer, [18 F]1, was obtained in a non-decay-corrected radiochemical yield of 8 ± 2% (n = 7) in >99% radiochemical and >95% chemical purity with a specific activity of 3174 ± 345 Ci/mmol (EOS). This new facile radiosynthesis routinely affords highly pure quantities of [18 F]1, which will further enable tracer development of OP cholinesterase inhibitors and their evaluation in vivo.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  [18F]-fluoroethanol; acetylcholinesterase; bis-(p-nitrophenyl) methylphosphonate; fluorine-18; positron emission tomography (PET); β-fluoroethoxyphosphonate

Mesh:

Substances:

Year:  2017        PMID: 28406525      PMCID: PMC6031433          DOI: 10.1002/jlcr.3511

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  17 in total

Review 1.  Chemical warfare agents: II. Nerve agents.

Authors:  F R Sidell; J Borak
Journal:  Ann Emerg Med       Date:  1992-07       Impact factor: 5.721

2.  Thionate versus Oxon: comparison of stability, uptake, and cell toxicity of ((14)CH(3)O)(2)-labeled methyl parathion and methyl paraoxon with SH-SY5Y cells.

Authors:  Sandip B Bharate; John M Prins; Kathleen M George; Charles M Thompson
Journal:  J Agric Food Chem       Date:  2010-07-28       Impact factor: 5.279

3.  Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain.

Authors:  R A Koeppe; K A Frey; S E Snyder; P Meyer; M R Kilbourn; D E Kuhl
Journal:  J Cereb Blood Flow Metab       Date:  1999-10       Impact factor: 6.200

4.  In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP).

Authors:  M R Kilbourn; S E Snyder; P S Sherman; D E Kuhl
Journal:  Synapse       Date:  1996-02       Impact factor: 2.562

5.  Comparison of inhibition kinetics of several organophosphates, including some nerve agent surrogates, using human erythrocyte and rat and mouse brain acetylcholinesterase.

Authors:  Alper Coban; Russell L Carr; Howard W Chambers; Kenneth O Willeford; Janice E Chambers
Journal:  Toxicol Lett       Date:  2016-03-07       Impact factor: 4.372

6.  Synthesis and anti-acetylcholinesterase properties of novel β- and γ-substituted alkoxy organophosphonates.

Authors:  S Kaleem Ahmed; Yamina Belabassi; Lakshmi Sankaranarayanan; Chih-Kai Chao; John M Gerdes; Charles M Thompson
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

Review 7.  Acetylcholinesterase imaging: its use in therapy evaluation and drug design.

Authors:  Hitoshi Shinotoh; Kiyoshi Fukushi; Shin-ichiro Nagatsuka; Toshiaki Irie
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

8.  f-[18F]fluoroethanol and 3-[18F]fluoropropanol: facile preparation, biodistribution in mice, and their application as nucleophiles in the synthesis of [18F]fluoroalkyl aryl ester and ether PET tracers.

Authors:  Jinhe Pan; Maral Pourghiasian; Navjit Hundal; Joseph Lau; François Bénard; Shoukat Dedhar; Kuo-Shyan Lin
Journal:  Nucl Med Biol       Date:  2013-06-14       Impact factor: 2.408

9.  PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor.

Authors:  B Bencherif; C J Endres; J L Musachio; A Villalobos; J Hilton; U Scheffel; R F Dannals; S Williams; J J Frost
Journal:  Synapse       Date:  2002-07       Impact factor: 2.562

10.  Preparation and preliminary biodistribution of "no carrier added" fluorine1-8 fluoroethanol.

Authors:  T J Tewson; M J Welch
Journal:  J Nucl Med       Date:  1980-06       Impact factor: 10.057

View more
  5 in total

Review 1.  Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.

Authors:  Charles M Thompson; John M Gerdes; Henry F VanBrocklin
Journal:  Neurobiol Dis       Date:  2019-04-22       Impact factor: 5.996

2.  The inhibition, reactivation and mechanism of VX-, sarin-, fluoro-VX and fluoro-sarin surrogates following their interaction with HuAChE and HuBuChE.

Authors:  Chih-Kai Chao; Narayanaganesh Balasubramanian; John M Gerdes; Charles M Thompson
Journal:  Chem Biol Interact       Date:  2018-06-18       Impact factor: 5.192

3.  Positron emission tomography evaluation of oxime countermeasures in live rats using the tracer O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate [18 F]-VXS.

Authors:  Thomas R Hayes; Joseph E Blecha; Chih-Kai Chao; Tony L Huynh; Henry F VanBrocklin; Kurt R Zinn; Palmer W Taylor; John M Gerdes; Charles M Thompson
Journal:  Ann N Y Acad Sci       Date:  2020-05-20       Impact factor: 5.691

4.  Radiosynthesis of O-(1-[18 F]fluoropropan-2-yl)-O-(4-nitrophenyl)methylphosphonate: A novel PET tracer surrogate of sarin.

Authors:  Thomas R Hayes; Charles M Thompson; Joseph E Blecha; John M Gerdes; Henry F VanBrocklin
Journal:  J Labelled Comp Radiopharm       Date:  2018-11-04       Impact factor: 1.921

5.  Biological Distribution and Metabolic Profiles of Carbon-11 and Fluorine-18 Tracers of VX- and Sarin-Analogs in Sprague-Dawley Rats.

Authors:  Thomas R Hayes; Chih-Kai Chao; Joseph E Blecha; Tony L Huynh; Kurt R Zinn; Charles M Thompson; John M Gerdes; Henry F VanBrocklin
Journal:  Chem Res Toxicol       Date:  2020-12-29       Impact factor: 3.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.